SNOMED CT Templates

Page tree

StatusFor review
Version

0.6

Descriptions:

Termdescription typeLanguage/acceptabilityLanguage/acceptabilityCase significance
[characteristic] [compositional material] [body structure] stent (physical object)FSNus:Pgb:Pci
[characteristic] [compositional material] [body structure] stent
SYNus:Pgb:Pci

Concept model:

Attribute cardinalityAttributeValueRole group cardinality
1..1

116680003 |Is a (attribute)|

65818007 |Stent (physical object)|

N/A
0..1

836358009 |Has device intended site (attribute)|

<  123037004 |Body structure (body structure)|

0..*

840562008 |Has device characteristic (attribute)|

<  362981000 |Qualifier value (qualifier value)|

0..*

840560000 |Has compositional material (attribute)|

<  105590001 |Substance (substance)|

Definition status:  



Applies To:

<<  65818007 |Stent (physical object)|


Template Language

65818007 |Stent (physical object)|  : [[~0..1]]  836358009 |Has device intended site (attribute)|   = [[ +id (<  123037004 |Body structure (body structure)| ) @site]], [[~0..*]]   840562008 |Has device characteristic (attribute)|  = [[+id(<  362981000 |Qualifier value (qualifier value)| ) @charact ]], [[~0..*]]   840560000 |Has compositional material (attribute)|  = [[+id(<  105590001 |Substance (substance)| )]]


Rules for description generation:

  1. Apply General rules for generating descriptions for templates;

JIRA tickets:



2 Comments

  1. Yongsheng Gao

    Hi Suzanne Santamaria , just double check if attribute 'Has active ingredient' will not be used for drug eluting stent (product).

    If these three attributes are potentially applicable to all devices, should we consider creating a single template for all devices? Then, different subhierarchies will need to choose a specific proximal primitive parent during authoring. Do we have any estimation on the number of similar templates? 

    1. Suzanne Santamaria

      Hi Yongsheng Gao, we think 'Has active ingredient' may be used for drug eluting stent (product). If I recall correctly, we are postponing the modeling of the drug eluting stents until we can evaluate them further (Toni Morrison ?). I think it is worth discussing whether we need a template for each subhierarchy of devices as the number of templates could end up being quite large. There may be around 15-20 templates for implants alone. Implants are the target of the first phase of the project and may take a couple of years to complete given the current low resource allocation for the project. Thanks, Suzanne